&nbsp;

MHCW-WOSRCPDAPFormThoracic.pdf

Jun 2018

Document

maps_hpb_locations-20-6-18.html

Jun 2018

Document

mammogramLocations-22-6-18.xml

Jun 2018

Regimen

MFOLFOX6

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Document

mammogram_site_locations-july-8-2018.xml

Aug 2018

Regimen

MEGETMXF

Cancer Type:

Gynecologic,

Endometrial

Intent: Palliative

Funding:

ODB - General Benefit

megestrol - oral tablets

ODB - General Benefit

tamoxifen

Drugs Used:

megestrol,

tamoxifen

Quick Link(s):

Regimen Monograph

May 2019

Document

mammogramLocations-14-9-18.xml

Sep 2018

Regimen

FC+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FC(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

oBINutuzumab,

fludarabine (Unfunded),

cyclophosphamide

Quick Link(s):

Regimen Monograph

May 2019

Regimen

FCM(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

oBINutuzumab,

mitoXANTRONE,

fludarabine (Unfunded),

cyclophosphamide

Quick Link(s):

Regimen Monograph

May 2019

Regimen

FCM+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

FLUD+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

Drugs Used:

oBINutuzumab,

fludarabine